NEOG vs ZTS
NEOG: Neogen is a global provider of diagnostics and biosecurity solutions dedicated to ensuring the safety and quality of the world's food and animal supply. ZTS: Zoetis is a leader in the global animal health industry, providing a broad range of innovative medicines, vaccines, and diagnostics for pets and livestock.
Side-by-side fundamentals
| Metric | NEOG | ZTS | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $11.71 | $73.08 | |
| Market cap | $2.6B | $30.2B | |
| P/E as of 2026-10-08 | n/a | 12.02 | |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | n/a | 1.17 | |
| Net margin | -0.9% | +28.2% | ZTS higher |
| Gross margin FY2026, SEC XBRL | +46.9% | n/a | |
| Operating margin FY2026, SEC XBRL | -2.5% | n/a | |
| ROE | -0.4% | +80.2% | ZTS higher |
| ROA | -0.2% | +17.3% | ZTS higher |
| Debt / equity as of 2026-09-03 | 0.38 | 2.87 | NEOG lower |
| Revenue growth (YoY) as of 2026-09-03 | -2.7% | +1.4% | ZTS higher |
| Revenue CAGR (3y) SEC XBRL | +1.9% | +5.4% | ZTS higher |
| Dividend yield as of 2026-09-02 | n/a | +3.0% | |
| Dividend streak (yrs) SEC XBRL | 0 | 13 | ZTS higher |
| Beta as of 2026-09-03 | 0.31 | 0.56 | |
| 1-year return as of 2026-10-08 close | +101.2% | -49.1% | NEOG higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.